top of page
%20BIANCO.png)
Pipeline
Our compounds target components of the solid tumor microenvironment to foster anti-cancer immune response enhancing the recruitment, activation and sustained function of cytotoxic T lymphocytes against solid tumors.
Our approach aims at reprogramming the solid tumor microenvironment to unlock the full potential of cancer immunotherapy.
Join Lever Bio in advancing promising research and driving innovative drug development in the immuno-oncology field
News & Updates
bottom of page